A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab
Kunal Desai, Landon C. Brown, Wei Wei, Matthew D. Tucker, Chester Kao, Emily N. Kinsey, Brian I. Rini, Kathryn E. Beckermann, Tian Zhang, Moshe Chaim Ornstein
Topics & Concepts
MedicineNivolumabIpilimumabRenal cell carcinomaInternal medicineProportional hazards modelRetrospective cohort studyResponse Evaluation Criteria in Solid TumorsOncologyMedical recordProgression-free survivalProgressive diseaseMultivariate analysisPerformance statusSurvival analysisCancerKidney cancerSurgeryDiseaseImmunotherapyChemotherapyRenal cell carcinoma treatmentManagement of metastatic bone diseaseBiomarkers in Disease Mechanisms